HomeCompareSCVPF vs PFE

SCVPF vs PFE: Dividend Comparison 2026

SCVPF yields 3.09% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $29.4K in total portfolio value· pulled ahead in Year 8
10 years
SCVPF
SCVPF
● Live price
3.09%
Share price
$4.89
Annual div
$0.15
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.31
Full SCVPF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SCVPF vs PFE

📍 PFE pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCVPFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCVPF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCVPF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCVPF
Annual income on $10K today (after 15% tax)
$263.00/yr
After 10yr DRIP, annual income (after tax)
$0.26/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,319.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCVPF + PFE for your $10,000?

SCVPF: 50%PFE: 50%
100% PFE50/50100% SCVPF
Portfolio after 10yr
$34.9K
Annual income
$13,129.52/yr
Blended yield
37.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SCVPF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.6
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCVPF buys
0
PFE buys
0
No recent congressional trades found for SCVPF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCVPFPFE
Forward yield3.09%6.13%
Annual dividend / share$0.15$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$20.2K$49.6K
Annual income after 10y$0.31$26,258.71
Total dividends collected$312.00$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: SCVPF vs PFE ($10,000, DRIP)

YearSCVPF PortfolioSCVPF Income/yrPFE PortfolioPFE Income/yrGap
1$10,855$154.70$9,153$693.39+$1.7KSCVPF
2$11,693$78.47$8,593$849.25+$3.1KSCVPF
3$12,551$39.50$8,336$1,066.78+$4.2KSCVPF
4$13,449$19.81$8,437$1,384.80+$5.0KSCVPF
5$14,401$9.92$9,013$1,875.40+$5.4KSCVPF
6$15,414$4.96$10,306$2,680.72+$5.1KSCVPF
7$16,495$2.48$12,820$4,101.38+$3.7KSCVPF
8← crossover$17,651$1.24$17,673$6,826.70$22.00PFE
9$18,887$0.62$27,543$12,591.86$8.7KPFE
10$20,210$0.31$49,560$26,258.71$29.4KPFE

SCVPF vs PFE: Complete Analysis 2026

SCVPFStock

The Siam Cement Public Company Limited, together with its subsidiaries, operates in the cement and building materials, chemicals, and packaging businesses in Thailand and internationally. It operates through SCG Cement and Green Solutions, SCG Smart Living and Distributorship and Retail, SCG Décor, SCG Chemicals SCGC, SCGP, and other segments. The SCG Cement and Green Solutions segment produces cement, ready-mixed concrete, precast and post-tension, industrial solutions, waste management services, 3D printing, and advanced materials. Its SCG Smart Living and Distributorship and Retail segment engages in manufacturing of construction materials, including roofing tiles, board and wood substitutions, landscape products, thermal insulation, and autoclaved aerated concrete, as well as housing-related products and services, including solar solutions, fresh air ventilation systems and ventilation systems, modular home building services, and end-to-end roofing solutions; and SCG Distribution and Retail engages in distribution and retailing of cement, building materials, and other home & living products, as well as provides international supply chain solutions, and invests in logistics businesses. The SCG Decor segment engages in production and distributing ceramic tiles, sanitary ware, and related products, services and solutions. Its SCG Chemicals SCGC segment manufactures and sells olefins, polyolefins, vinyl, other chemical products, and providing industrial service and solutions; and SCGP segment engages in integrated packaging of fiber packaging, packaging paper, consumer and performance packaging, and medical supplies and labware; as well as fibrous business consisting of foodservice packaging and pulp and paper products; and recycling of packaging material. The other segment engages in clean energy business, pertinent technologies, and investment in other business. The Siam Cement Public Company Limited was founded in 1913 and is headquartered in Bangkok, Thailand.

Full SCVPF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SCVPF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCVPF vs SCHDSCVPF vs JEPISCVPF vs OSCVPF vs KOSCVPF vs MAINSCVPF vs JNJSCVPF vs MRKSCVPF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.